secwatch.observer — SEC 8-K summary
======================================

Issuer:     Envoy Medical, Inc. (COCH)
CIK:        0001840877
Form:       8-K
Filed at:   2026-05-18T20:05:41+00:00
Accession:  0001213900-26-058429
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Stockholders approve 6M extra shares for equity plan and 1.2M for ESPP
----------------------------------------------------------------------

- 6,000,000 additional shares authorized under Amended and Restated 2023 Equity Incentive Plan (effective May 12, 2026).
- 1,200,000 additional shares authorized under 2023 Employee Stock Purchase Plan.
- Stockholders re-elected directors Brent T. Lucas and Susan J. Kantor to Class III terms until 2029.
- Ratified EisnerAmper LLP as independent auditor for fiscal year ending December 31, 2026.
- Approved advisory executive compensation and issuance of warrants per Nasdaq Rule 5635(d).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840877/000121390026058429/0001213900-26-058429-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840877/000121390026058429/ea0291354-8k_envoy.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-058429

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer